Company intelligence / Profile preview

Scayan

Ownership: Private
Development stage: Commercial

Overview

Scayan provides a holistic digital and expert-driven service for corporate and employee health. Its "Happy Cells" platform focuses on improving energy, resilience, and overall well-being through empowerment, motivation strategies, personalized support from experts, and measurable impact assessments. The company is certified by the Society for Prevention (GPeV) and recognized as a top brand in corporate health by EUPD Research. It does not conduct clinical trials but measures outcomes via its proprietary tools.

Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Certified by GPeVRecognized by EUPD Research as Top Brand Corporate Health 2022

Beyond the preview

Go deeper on Scayan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scayan.

Explore the full profile